The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lanoxin 250 microgram Tablets

Aspen Pharma Trading LimitedPA1691/001/004

Main Information

Trade NameLanoxin 250 microgram Tablets
Active SubstancesDigoxin
Dosage FormTablet
Licence HolderAspen Pharma Trading Limited
Licence NumberPA1691/001/004

Group Information

ATC CodeC01AA Digitalis glycosides
C01AA05 digoxin


License statusAuthorised
Licence Issued01/04/1980
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back